Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Foehr Matthew W
Relationship:   President and CEO, Dir...
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   4,011,238    

Indirect Shares

   0      
Direct Value   $32,630,873    

Indirect Value

   $0      
Total Shares   4,011,238      
Total Value   $32,630,873      


Ligand Pharmaceuticals Inc $13,352,856 Viking Therapeutics, Inc. $5,648,163 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $13,568,856 Ligand Pharmaceuticals Inc $13,352,856 Viking Therapeutics, Inc. $5,648,163 Qualigen Therapeutics Inc $60,999 OmniAb, Inc $13,568,856
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    4    

     Stock price went up :
    6   
    0    
     Stock price went down :
    7   
    4    
   
     Gain/Loss Ratio :
   0.0   
   -4.0   
     Percentage Gain/Loss :
   32.7%
 -89.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ligand Pharmaceuticals Inc LGND Former Executive Officer 2022-11-01 162,187 2011-04-18 0    Premium*  
            Viking Therapeutics, Inc. VKTX Director 2022-05-02 111,250 2015-05-04 0    Premium*  
            Qualigen Therapeutics Inc QLGN Director 2020-04-10 138,635 2015-06-24 0    Premium*  
            OmniAb, Inc OABI President and CEO, Dir... 2024-06-27 3,599,166 2022-11-01 0    Premium*  
* Premium Members only  

Records found :    137         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-13 4 A $0.00 $0 D/D 7,396 156,229 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-14 4 OE $14.47 $104,546 D/D 7,225 163,454 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-14 4 AS $95.84 $692,467 D/D (7,225) 156,229 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-15 4 D $97.23 $241,714 D/D (2,486) 153,743 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-27 4 OE $14.47 $141,941 D/D 8,931 155,449 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-02-27 4 AS $110.00 $794,750 D/D (7,225) 153,743 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-03-13 4 OE $21.92 $43,840 D/D 2,000 157,449 0 -
QLGN Qualigen Therapeutics Inc Director   –       •      –    2020-04-10 4 A $0.00 $0 D/D 38,461 138,635 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2020-06-30 4 S $7.35 $95,550 D/D (13,000) 26,250 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-21 4 AS $112.88 $815,541 D/D (7,225) 155,413 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-21 4 OE $14.47 $163,338 D/D 8,015 162,638 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-24 4 AS $110.89 $8,649 D/D (78) 155,413 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2020-08-24 4 OE $21.92 $1,710 D/D 78 155,491 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-01-25 4 D $156.01 $518,733 D/D (3,325) 160,603 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-01-25 4 A $0.00 $0 D/D 8,515 162,875 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-02-03 4 A $0.00 $0 D/D 6,595 167,198 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-02-04 4 S $176.86 $7,878,582 D/D (44,547) 168,198 0 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-02-04 4 OE $21.92 $1,050,890 D/D 45,547 212,745 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-02-15 4 D $172.46 $534,281 D/D (3,098) 165,100 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2021-03-22 4 OE $1.50 $30,000 D/D 20,000 46,250 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-05-28 4 GD $0.00 $0 D/D 2,500 162,600 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-05-28 4 OE $56.26 $98,736 D/D 1,755 164,355 0 -
VKTX Viking Therapeutics, Inc. Director   –       •      –    2021-06-10 4 B $5.69 $113,800 D/D 20,000 66,250 2.39 %
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-08-04 4 OE $21.92 $291,745 D/D 9,982 165,497 0 -
LGND Ligand Pharmaceuticals In... President and COO   •       –      –    2021-08-04 4 S $109.67 $969,507 D/D (8,840) 164,355 0 %
  137  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us